The Recall Desk

Manufacturer

Genzyme Corporation

6 recalls in our database name Genzyme Corporation as the manufacturing or recalling firm.

What the numbers show

Total
6
Critical
0
Severe
2
Most recent
2017-11-22

Of the 6 recalls from Genzyme Corporation we have scored against our rubric, 0 (0%) are Critical — deaths or serious injuries reported, or the agency’s own highest classification — and 2 (33%) are Severe.

Which agencies issued them

About this listing

The manufacturer string comes from the agency’s own source notice — for FDA recalls, the “recalling firm” field; for NHTSA recalls, the vehicle manufacturer; for CPSC recalls, the firm-of-record on the joint press release. A single corporate family can appear under multiple manufacturer strings as agency notices aren’t standardized on a canonical name. If you don’t see recalls you expect, try a parent-company search or a broader full-text search.

Severity scores below are computed from the agency’s classification and the recall text, never from manufacturer behaviour or history. Many manufacturers issue routine corrective actions (software updates, labelling corrections) that are correctly scored low — having recalls on this list isn’t inherently a quality signal.

1–6 of 6

  • LowFDA (Drugs)·D-0075-2018·2017-11-22

    Genzyme Recalls Clolar Injection Due to Missing Package Insert

    Genzyme Corporation is recalling Clolar (clofarabine) injection vials because the package insert is incorrect or missing.

    Product
    Clolar (clofarabine) 20 mg/20 mL (1 mg/mL) Injection, for intravenous use, Rx Only, Mfd. by: Teva Pharmachemie Swensweg 5 Haarlem, The Netherlands Mfd. for: Genzyme Corporation, Cambridge, MA 02142, NDC 0024-5860-01.
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-0729-2016·2016-03-09

    Genzyme Recalls Thyrogen Injection Vials Due to Glass Particulate Matter

    Genzyme Corporation is recalling 27,022 vials of Thyrogen (thyrotropin alfa) because glass particles were found in the product after reconstitution.

    Product
    Thyrogen (thyrotropin alfa for injection), 0.9 mg/mL after reconstitution, For intramuscular injection only, Rx Only, Four vials per Carton, Carton contains 2 vials of Thyrogen and 2 vials of diluent, Storage: store at 2-8 C, Genzyme Corporation, Cambridge, MA 02142, NDC 58468-1
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-0730-2016·2016-03-09

    Genzyme Recalls Thyrogen Due to Glass Particles Found in Product

    Genzyme Corporation is recalling specific lots of Thyrogen (thyrotropin alfa) because glass particles were found in the product after reconstitution.

    Product
    THYROGEN — THYROGEN (THYROTROPIN ALFA)
    Category
    Drug
    Distribution
    Distributed nationwide
  • HighFDA (Devices)·Z-1855-2012·2012-06-27

    Genzyme Recalls Seprafilm Adhesion Barrier Packs Due to Packaging Defect

    Genzyme is recalling Seprafilm Procedure Packs because a packaging defect may compromise the product's sterility. The recall affects units distributed in the US and South Korea.

    Product
    seprafilm¿ Procedure Pack ADHESION BARRIER Re-order Number: 5086-02 Product Usage: Seprafilm Adhesion Barrier is indicated for use in patients undergoing abdominal or pelvic laparotomy as an adjunct intended to reduce the incidence, extent and severity of postoperative adh
    Category
    Medical Device
    Distribution
    Distributed nationwide
  • HighFDA (Devices)·Z-1856-2012·2012-06-27

    Genzyme Recalls Seprafilm Adhesion Barrier Due to Packaging Sterility Risk

    Genzyme Corporation is recalling 1,285 units of Seprafilm Single Site Adhesion Barrier because a packaging defect may compromise product sterility.

    Product
    seprafilm¿ Single Site ADHESION BARRIER Re-order Number: 6641-01 Product Usage: Seprafilm Adhesion Barrier is indicated for use in patients undergoing abdominal or pelvic laparotomy as an adjunct intended to reduce the incidence, extent and severity of postoperative adhesion
    Category
    Medical Device
    Distribution
    Distributed nationwide

About this company

Community-sourced company facts from Wikidata, not from any recall agency. This is background on the corporate entity — it says nothing about the recall(s) listed on this page, which come from the agency source notice above.

Genzyme

company

Country
United States
Founded
1981
Parent company
Sanofi

Official website

Source: Wikidata (Q1502740), licensed CC0. Wikidata is community-edited and may not reflect the current corporate structure.